Meta-analysis of randomized trials comparing the effectiveness of different strategies for the treatment of drug-eluting stent restenosis

American Journal of Cardiology

Volumn 114, Issue 9, 2014, Pages 1339-1346

  Piccolo, Raffaele ^a   Galasso, Gennaro ^a   Piscione, Federico ^b   Esposito, Giovanni ^a   Trimarco, Bruno ^a   Dangas, George D ^c   Mehran, Roxana ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; IOPROMIDE; PACLITAXEL; RAPAMYCIN;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; DRUG ELUTING STENT; DRUG ELUTING STENT RESTENOSIS; EVEROLIMUS ELUTING STENT; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; META ANALYSIS; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIROLIMUS ELUTING STENT; CORONARY RESTENOSIS; PRACTICE GUIDELINE; PROCEDURES; PROSTHESIS FAILURE; STANDARDS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84908067625     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.07.069     Document Type: Article

References (29)

1. G.G. Stefanini, and D.R. Holmes Jr. Drug-eluting coronary-artery stents N Engl J Med 368 2013 254 265
2. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
3. V. Farooq, B.D. Gogas, and P.W. Serruys Restenosis: delineating the numerous causes of drug-eluting stent restenosis Circ Cardiovasc Interv 4 2011 195 205
4. K. Ishikawa, Y. Aoyama, and H. Hirayama Management of drug-eluting stent restenosis J Invasive Cardiol 24 2012 178 182
5. J.S. Douglas Jr. Drug-eluting stent restenosis: a need for new technology? JACC Cardiovasc Interv 5 2012 738 740
6. D.M. Caldwell, A.E. Ades, and J.P. Higgins Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 2005 897 900
7. G. Lu, and A.E. Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 2004 3105 3124
8. J.P. Higgins, and S. Green Chapter 8: Assessing Risk of Bias in Included Studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011 The cochrane collaboration Available at: www.Cochrane-handbook.Org Accessed May 15, 2014
9. G. van Valkenhoef, T. Tervonen, T. Zwinkels, B. de Brock, and H. Hillege ADDIS: a decision support system for evidence-based medicine Decis Support Syst 55 2013 459 475
10. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
11. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
12. H.Y. Wu, J.W. Huang, H.J. Lin, W.C. Liao, Y.S. Peng, K.Y. Hung, K.D. Wu, Y.K. Tu, and K.L. Chien Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and Bayesian network meta-analysis BMJ 347 2013 f6008
13. S.P. Brooks, and A. Gelman General methods for monitoring convergence of iterative simulations J Comput Graphical Stat 7 1998 434 455
14. S. Dias, N.J. Welton, D.M. Caldwell, and A.E. Ades Checking consistency in mixed treatment comparison meta-analysis Stat Med 29 2010 932 944
15. A. Cipriani, T.A. Furukawa, G. Salanti, J.R. Geddes, J.P. Higgins, R. Churchill, N. Watanabe, A. Nakagawa, I.M. Omori, H. McGuire, M. Tansella, and C. Barbui Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 2009 746 758
16. G. Salanti, A.E. Ades, and J.P. Ioannidis Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial J Clin Epidemiol 64 2011 163 171
17. B. Chevalier, R. Moulichon, E. Teiger, P. Brunel, J.P. Metzger, M. Pansieri, D. Carrie, H.P. Stoll, K. Wittebols, C. Spaulding, and J. Fajadet One-year results of the CRISTAL trial, a randomized comparison of Cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents J Interv Cardiol 25 2012 586 595
18. S. Habara, K. Mitsudo, K. Kadota, T. Goto, S. Fujii, H. Yamamoto, H. Katoh, N. Oka, Y. Fuku, S. Hosogi, A. Hirono, T. Maruo, H. Tanaka, Y. Shigemoto, D. Hasegawa, H. Tasaka, M. Kusunose, S. Otsuru, Y. Okamoto, N. Saito, Y. Tsujimoto, H. Eguchi, K. Miyake, and M. Yoshino Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis JACC Cardiovasc Interv 4 2011 149 154
19. J. Mehilli, R.A. Byrne, K. Tiroch, S. Pinieck, S. Schulz, S. Kufner, S. Massberg, K.L. Laugwitz, A. Schomig, and A. Kastrati Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
20. R.A. Byrne, F.J. Neumann, J. Mehilli, S. Pinieck, B. Wolff, K. Tiroch, S. Schulz, M. Fusaro, I. Ott, T. Ibrahim, J. Hausleiter, C. Valina, J. Pache, K.L. Laugwitz, S. Massberg, and A. Kastrati Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
21. H. Rittger, J. Brachmann, A.M. Sinha, M. Waliszewski, M. Ohlow, A. Brugger, H. Thiele, R. Birkemeyer, V. Kurowski, O.A. Breithardt, M. Schmidt, S. Zimmermann, S. Lonke, M. von Cranach, T.V. Nguyen, W.G. Daniel, and J. Wohrle A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the pepcad-des study J Am Coll Cardiol 59 2012 1377 1382
22. B. Xu, R. Gao, J. Wang, Y. Yang, S. Chen, B. Liu, F. Chen, Z. Li, Y. Han, G. Fu, Y. Zhao, and J. Ge A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD CHINA ISR trial JACC Cardiovasc Interv 7 2014 204 211
23. H.G. Song, D.W. Park, Y.H. Kim, J.M. Ahn, W.J. Kim, J.Y. Lee, S.J. Kang, S.W. Lee, C.W. Lee, S.W. Park, S. Han, I.W. Seong, N.H. Lee, B.K. Lee, K. Lee, S.W. Lee, D.Y. Nah, and S.J. Park Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation J Am Coll Cardiol 59 2012 1093 1100
24. R. Mehran, G. Dangas, A.S. Abizaid, G.S. Mintz, A.J. Lansky, L.F. Satler, A.D. Pichard, K.M. Kent, G.W. Stone, and M.B. Leon Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
25. P. Agostoni, A. Belkacemi, M. Voskuil, H.M. Nathoe, P.A. Doevendans, and P.R. Stella Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve JACC Cardiovasc Interv 6 2013 569 576
26. G. Campo, M. Tebaldi, P. Vranckx, S. Biscaglia, C. Tumscitz, R. Ferrari, and M. Valgimigli Short- versus long-term duration of dual antiplatelet therapy in patients treated for in-stent restenosis: a PRODIGY trial substudy (prolonging dual antiplatelet treatment after grading stent-induced intimal hyperplasia) J Am Coll Cardiol 63 2014 506 512
27. F. Alfonso, M.J. Perez-Vizcayno, A. Cardenas, B. Garcia Del Blanco, B. Seidelberger, A. Iniguez, M. Gomez-Recio, M. Masotti, M.T. Velazquez, J. Sanchis, A. Garcia-Touchard, J. Zueco, A. Bethencourt, R. Melgares, A. Cequier, A. Dominguez, V. Mainar, J.R. Lopez-Minguez, J. Moreu, V. Marti, R. Moreno, P. Jimenez-Quevedo, N. Gonzalo, C. Fernandez, and C. Macaya A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis: the RIBS V clinical trial J Am Coll Cardiol 63 2014 1378 1386
28. S. Cassese, R. Piccolo, G. Galasso, R. De Rosa, and F. Piscione Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials Int J Cardiol 150 2011 84 89
29. P. Bondesson, B. Lagerqvist, S.K. James, G.K. Olivecrona, D. Venetsanos, and J. Harnek Comparison of two drug-eluting balloons: a report from the SCAAR registry EuroIntervention 8 2012 444 449